Biologic treatment for severe asthma listed on PBS

A new pre-filled autoinjector for at-home administration of mepolizumab will be reimbursed by the PBS from 1 June Patients with severe refractory eosinophilic asthma can now choose to receive treatment with Nucala (mepolizumab) in clinic or to self-administer at home, with both options now subsidised by the government under the PBS. In late 2016, mepolizumab